SIMBA GILL - 12 Sep 2022 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Director
Signature
/s /Allan Reine, M.D., Attorney-in-Fact
Issuer symbol
FHTX
Transactions as of
12 Sep 2022
Transactions value $
$59,860
Form type
4
Filing time
14 Sep 2022, 20:59:49 UTC
Previous filing
22 Jun 2022
Next filing
09 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FHTX Common Stock Options Exercise $59.9K +82K $0.73* 82K 12 Sep 2022 Direct
transaction FHTX Common Stock Gift $0 -47.9K -58.46% $0.00 34.1K 13 Sep 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FHTX Stock Options (Right to buy) Options Exercise $0 -82K -43.34% $0.00 107K 12 Sep 2022 Common Stock 82K $0.73 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a bona fide gift of Common Stock to a non-profit educational institution.
F2 The option vested as to 25% of the underlying shares of common stock on July 25, 2018, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter until the option was fully vested.